Serum‐derived microribonucleic acids as potential novel biomarkers for slowly progressive type 1 diabetes mellitus
ABSTRACT Objectives We aimed to identify microribonucleic acids (miRNAs) that could serve as biomarkers for slowly progressive type 1 diabetes mellitus (SPIDDM). Materials and Methods We conducted a retrospective study of adult patients with SPIDDM who fulfilled the criteria for SPIDDM (definite) (n = 60), type 2 diabe...